JNJ's REMICADE Holds: PFE's Results To Confirm
Johnson & Johnson (JNJ US) reported Q2 2017 results today (quotes from earnings call are below). US revenue for REMICADE (reference product for...
511 Views
Celltrion Healthcare IPO Part 5 - Regulatory Concerns & Possible M&A Options
Korea's Anti-Trust Law now says that any business group (those so-called chaebols or large conglomerates) with combined assets of ₩10tril are...
186 Views
Valuation of Celltrion + Celltrion Healthcare Is Not as Expensive as Samsung Biologics
Celltrion Healthcare (091990 KS) (CH) is raising US$701 - 884m in its upcoming IPO. Proceeds raised will be used to fund general working capital,...
295 Views
Celltrion Healthcare IPO Part 4 - Valuation & Pricing Debate
Celltrion Healthcare (091990 KS)'s bookbuilding is now in progress among overseas investors, and local bookbuilding will begin tomorrow and end on...
275 Views
Celltrion Healthcare IPO Part 3 - What Local Institutions Seem to Have in Mind
Celltrion Healthcare (091990 KS) officials are currently meeting Korea's local institutional investors for its IPO. Local roadshow began on June...
279 Views